Navigation Links
Beckman Coulter Announces Second Quarter 2008 Results
Date:7/25/2008

2008 2007

GAAP operating income $142.3 $130.3

Reconciling items*:

Restructuring expenses (a) 5.4 10.5

HCV sublicense (b) 12.0 -

Fair market value inventory adjustment (d) 1.0 -

Rental tax dispute (e) - 1.6

Adjusted operating income $160.7 $142.4

GAAP operating margin 9.3% 10.0%

Impact of adjustments 1.2% 0.9%

Adjusted operating margin 10.5% 10.9%

*See accompanying Non-GAAP Financial Measures section for description of Non-GAAP adjustments

BECKMAN COULTER, INC.

RECONCILIATION OF GAAP NET EARNINGS TO ADJUSTED NET EARNINGS

(in millions, except amounts per share)

(unaudited)

Three Months Ended June 30,

2008 2007

Per Diluted Per Diluted

Amount Share Amount Share

GAAP net earnings $47.8 $0.74 $69.4 $1.09

Reconciling items*:

Restructuring expenses (a) 4.7 0.07 3.6 0.06

HCV sublicense (b) 12.0 0.19 - -

Miami vacant land sale (c) (1.2) (0.02) - -

Rental tax dispute (e) - - 2.4 0.04

Biosite break-up fee (f) - - (40.6) (0.64)

Adjustment for income taxes (5.9) (0.09) 13.0 0.20

Adjusted net earnings $57.4
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Beckman Coulter Announces Second Quarter 2008 Earnings to be Released on Friday, July 25, 2008, Before Market Opens
2. Upcoming Beckman Coulter Investor Events Second Half of 2008
3. Beckman Coulter to Present at Upcoming Healthcare Conferences
4. Beckman Coulter Announces First Quarter 2008 Results
5. Beckman Coulter Acquires Rights to Hepatitis C Virus
6. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
7. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
8. Beckman Coulter to Present at the 2008 Bear Stearns London Healthcare Conference
9. Beckman Coulter Releases the High-Volume UniCel(R) DxC 880i Integrated Work Cell
10. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards
11. Beckman Coulter to Present at the JPMorgan Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...man . , Whether it,s CD packaging, container...ncy Identification) are increasingly finding their...label objects or goods and identify them automatic...an read and process the data contained in the labe...uction conditions of up to 100 degrees Celsius. Bu...
(Date:11/24/2009)...rk investment bank KTA Capital,s client Neuren Pha...l convertible note private placement with a U.S. i...rranged by KTA Capital as Neuren,s exclusive place... New York (PRWEB) November 23, 2009 -- The indepen...uot;KTA Capital") has announced that its clie...
(Date:11/24/2009)...IK, Iceland, November 24 ...nced that it has received notice from,the Nasdaq S...tock will be,suspended as of November 30, 2009 and...nd Exchange Commission, which will remove deCODE,s...ompany files an appeal to the Nasdaq,Listing Quali...
(Date:11/24/2009)...IK, Iceland, November 24 ...nced the approval of all of its,"first day" motion... Delaware,(the "Bankruptcy Court"). deCODE last we...pter 11 of the United States Bankruptcy Code with ... by the Bankruptcy Court allow the company to cont...
Breaking Biology Technology:Intelligence inside metal components 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3
... , , , , , , In April, 198...California mountain road and changed the course of... conceived the Polymerase Chain Reaction (PCR).,... , , , As is shown in the figure, the...s that hybridize to opposite strands and flank ,...
... , , , , for prevention of car...44 646 100 units , Cat. No. 1 269 062 25... Description , , , Uracil-DNA Glycosyl...uracil , from single- and double-stranded D... of dUTP. The apyriminic sites formed by UNG ar...
... , , , , for amplification of up t... 314 200 reactions , , , , ,..., 2x concentrated High Fidelity PCR Master contain...tides and enzymes) needed for PCR. The mix contain...rase and Pwo DNA Polymerase[a thermostable , ...
Other Biology Technology:PCR principles 2PCR principles 3PCR principles 4Uracil-DNA Glycosylase 2High Fidelity PCR Master 2
(Date:11/25/2009)...cers and ambulance workers faced a terrifying resc...battled to save people from the collapsing Twin To...acuated as many people as they could in an area wh...ng their jobs even harder was the problem of poor ...ives jammed mobile networks with calls and the eme...
(Date:11/25/2009)...e linchpin of the environment, where atmosphere, b... students see soil as "just dirt" a place to grow...are challenged with the task of helping students a... soil in the environment. , A collaborative pro... University of Nebraska-Lincoln, Oregon State Univ...
(Date:11/25/2009)...sors recently received funding from the National S...icial to understanding the environment. The three ...assistant professor in the Department of Biologica...rate research projects. , His first project, tit...Functions from the Leaf to the Landscape," will ex...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3It's not just dirt! 2Kent State University professors focus research on the environment with grants totaling $890,000 2MarketsandMarkets 3A Global Autoimmune Treatment Market Worth US 2468 81 Billion by 2014 13750 1MarketsandMarkets 3A Global Autoimmune Treatment Market Worth US 2468 81 Billion by 2014 13750 2MarketsandMarkets 3A Global Autoimmune Treatment Market Worth US 2468 81 Billion by 2014 13750 3MarketsandMarkets 3A Global Autoimmune Treatment Market Worth US 2468 81 Billion by 2014 13750 4New hope for heart failure patients 55802 1New hope for heart failure patients 55802 2Derris Indica is CJP 26apos 3Bs New Nonfood Biodiesel Crop for Profitable Sustainability 13746 1Derris Indica is CJP 26apos 3Bs New Nonfood Biodiesel Crop for Profitable Sustainability 13746 2Derris Indica is CJP 26apos 3Bs New Nonfood Biodiesel Crop for Profitable Sustainability 13746 3
... Singapore scientists, led by Christopher Wong, Ph...e complete sequence of any influenza A virus, incl...pharyngeal wash from patients. , The new method,...of influenza A viruses and sequence them within a ...apore (GIS), one of the research institutes sponso...
...niversity at Buffalo researchers have demonstrated...ow stem cells into skeletal muscle can repair card...animal model, the researchers showed that this non...ells, by two-fold and reduced cardiac tissue injur...ion of the left ventricle, the primary pumping cha...
...am of scientists has cracked the problem of pod sh...ust before harvest, oilseed rape pods are prone to... 70% in some cases. , "By artificially producing ...ve stopped the fruit opening in the related model ...inside," says Dr Lars stergaard from the John Inne...
Other Biology News:Rapid approach to identify influenza A virus mutations and drug resistance developed 2Adult bone marrow stem cells injected into skeletal muscle can repair heart tissue 2Adult bone marrow stem cells injected into skeletal muscle can repair heart tissue 3Shatter-resistant brassicas 2
Mimic Sf9 Insect Cells from Invitrogen
Propidium iodide; solution (Available only in the U.S.) from Roche Applied Science
...lies, for 10 chips, provides the reagents and supp...alysis (picogram levels) with 10 chips on the Expe...e 1,250 microliters RNA gel, 20 microliters RNA Hi...liters RNA HighSens loading buffer, 100 microliter...
Mouse Anti-Human Non-SMC condensin II complex, subunit D3 (NCAPD3) Monoclonal Antibody, Unconjugated from Lifespan Biosciences
Biology Products: